medigraphic.com

2001, Number 3

<< Back Next >>

Rev Fac Med UNAM 2001; 44 (3)

Retinopathy in diabetics seen by different specialists

Lima Gv, de León OJ, Duarte TM, Rojas DJA

Language: Spanish
References: 13
Page: 109-112
PDF size: 48.50 Kb.


ABSTRACT

A retrospective study was performed to determine whether the proportion of diabetic retinopathy differs among patients treated by different medical specialists.
Method: Evaluations were divided into groups, according to the physician who referred them: group 1: endocrinologists; group 2: internists; group 3: general practitioners. The proportion of eyes with a) diabetic retinopathy, b) proliferative retinopathy and c) severe visual loss were compared in the three groups. Also, timing of referral, according to international guidelines was evaluated. Differences between groups were analyzed by χ2.
Results: Seven hundred and fifty-six eyes of 387 patients were evaluated. Two hundred and sixty-four eyes were assigned to group 1, 152 to group 2 and 340 to group 3. Overall rates of eyes with retinopathy, proliferative retinopathy and severe visual loss were 48%, 16% and 14% respectively. Diabetic retinopathy, proliferative retinopathy and severe visual loss were statistically less frequent in group 1 than in groups 2 and 3 (p ‹ 0.05). Groups 2 and 3 were not statistically different (p › 0.05). Retinopathy detection was not on time for any of the groups.
Discussion: Detection of retinopathy by the physician who treats diabetic patients and timely referral must be reinforced, especially during pre-degree training.


REFERENCES

  1. González VME, González VC, Arredondo PB, Stern MP. Diabetic retinopathy in Mexico. Prevalence and clinical characteristics. Arch Med Res 1994; 25: 355-360.

  2. González-Villalpando ME, Arredondo-Pérez B, González-Villalpando C. Retinopatía diabética: prevalencia y severidad. Registro Hospital Central Sur Pemex. Rev Mex Oftalmol 1994; 68: 61-66.

  3. Philips M, del Río I, Quiroz H. Oportunidades de reducir los costos del tratamiento de la retinopatía diabética en México. Boletín of Sanit Panam 1994; 117: 22-32.

  4. Ortega-Larrocea G, Ochoa-Contreras D, Salazar-León JA et al. Retinopatía diabética en niños y adolescentes diabéticos insulino-dependientes. Rev Mex Oftalmol. 1997; 71: 56-60.

  5. González VC, González VME, Martínez S et al. A diabetic retinopathy screening program as strategy for blindness prevention. Arch Med Res 1996; 28: 129.

  6. Academia Americana de Oftalmología. Curso de ciencias básicas y clínicas. Sección 12. Retina y vítreo. San Francisco: Academia Americana de Oftalmología, 1996: 70-86.

  7. American Diabetes Association. Retinopatía diabética. Declaración de posición. Diabetes Care 1999; 22 S1: S70.

  8. Fauci AS, Braunwald E, Isselbacher KJ et al. Harrison’s Principles of Internal Medicine. New York, McGraw-Hill, 14 ed. 1998.

  9. Secretaría de prevención y control de enfermedades. Coordinación de vigilancia epidemiológica, Actualización de la “Norma Oficial Mexicana NOM-015-SSA2-1994, para la prevención, tratamiento y control de la diabetes 199: 16.

  10. Towler HMA, Patterson JA, Lightman S. Diabetes and the eye. London, BMJ publishing group 1996. CD.

  11. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993; 16: 642-652.

  12. Ryan SJ. Retina. The CV. Mosby Company. St. Louis 1994; 2: 301.

  13. Islas AS, Lifshitz GA. Diabetes Mellitus. México, McGraw-Hill-Interamericana, 2a ed. 199: 240.




2020     |     www.medigraphic.com